Results 171 to 180 of about 10,093 (182)

Predicting and evaluating response to omalizumab in patients with severe allergic asthma

Respiratory Medicine, 2007
Kian Fan Chung, K F Chung, K Rabe
exaly  

Omalizumab rapidly decreases nasal allergic response and FcεRI on basophils☆

Journal of Allergy and Clinical Immunology, 2004
Thomas Casalé, Calman Prussin, F A Romero   +2 more
exaly  

Omalizumab

Reactions Weekly
  +4 more sources

Omalizumab

Reactions Weekly, 2008
openaire   +1 more source

Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: A retrospective clinical analysis

Journal of Dermatological Science, 2014
Martin Church, Martin Metz, Marcus Maurer   +2 more
exaly  

Omalizumab Treatment of Systemic Mast Cell Activation Disease: Experiences from Four Cases

Internal Medicine, 2011
Britta Haenisch, Martin Raithel, Gerhard J   +2 more
exaly  

Factors reducing omalizumab response in severe asthma

European Journal of Internal Medicine, 2018
Carlo Cavaliere, Alessandro Perrella, P Santus   +2 more
exaly  

Omalizumab-induced reductions in mast cell FcεRI expression and function

Journal of Allergy and Clinical Immunology, 2004
Sarbjit Saini, Alkis Togias, Donald Macglashan   +2 more
exaly  

Omalizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA): single-center experience in 18 cases

World Allergy Organization Journal, 2018
Dilşad Mungan, Omur Aydin, Zeynep Celebi Sozener   +2 more
exaly  

Persistency of response to omalizumab therapy in severe allergic (IgE-mediated) asthma

Allergy: European Journal of Allergy and Clinical Immunology, 2011
Klaus F Rabe, Marc Humbert
exaly